ZA200309723B - Detection of spore forming bacteria. - Google Patents
Detection of spore forming bacteria. Download PDFInfo
- Publication number
- ZA200309723B ZA200309723B ZA200309723A ZA200309723A ZA200309723B ZA 200309723 B ZA200309723 B ZA 200309723B ZA 200309723 A ZA200309723 A ZA 200309723A ZA 200309723 A ZA200309723 A ZA 200309723A ZA 200309723 B ZA200309723 B ZA 200309723B
- Authority
- ZA
- South Africa
- Prior art keywords
- seq
- spore forming
- forming bacteria
- probe
- gene
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title claims description 138
- 238000001514 detection method Methods 0.000 title claims description 37
- 239000000523 sample Substances 0.000 claims description 128
- 108090000623 proteins and genes Proteins 0.000 claims description 88
- 238000000034 method Methods 0.000 claims description 84
- 239000002773 nucleotide Substances 0.000 claims description 56
- 125000003729 nucleotide group Chemical group 0.000 claims description 56
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 49
- 238000003752 polymerase chain reaction Methods 0.000 claims description 47
- 239000000047 product Substances 0.000 claims description 36
- 150000007523 nucleic acids Chemical group 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 30
- 102000004169 proteins and genes Human genes 0.000 claims description 28
- 108020004414 DNA Proteins 0.000 claims description 27
- 238000012360 testing method Methods 0.000 claims description 26
- 241000193403 Clostridium Species 0.000 claims description 24
- 241000193755 Bacillus cereus Species 0.000 claims description 21
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000009396 hybridization Methods 0.000 claims description 17
- 101150042065 spo0A gene Proteins 0.000 claims description 17
- 108091092356 cellular DNA Proteins 0.000 claims description 15
- 230000003321 amplification Effects 0.000 claims description 14
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 14
- 230000028070 sporulation Effects 0.000 claims description 14
- 241000194107 Bacillus megaterium Species 0.000 claims description 12
- 230000002441 reversible effect Effects 0.000 claims description 12
- 241000193469 Clostridium pasteurianum Species 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 229920002678 cellulose Polymers 0.000 claims description 10
- 239000001913 cellulose Substances 0.000 claims description 10
- 244000063299 Bacillus subtilis Species 0.000 claims description 9
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 9
- 241000193386 Lysinibacillus sphaericus Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 108091036078 conserved sequence Proteins 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 5
- 239000007795 chemical reaction product Substances 0.000 claims description 5
- 210000003608 fece Anatomy 0.000 claims description 5
- 239000002689 soil Substances 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 241000193738 Bacillus anthracis Species 0.000 claims description 4
- 229940065181 bacillus anthracis Drugs 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 230000009897 systematic effect Effects 0.000 claims description 4
- 229920001131 Pulp (paper) Polymers 0.000 claims description 3
- 239000003570 air Substances 0.000 claims description 3
- 238000009877 rendering Methods 0.000 claims description 3
- 230000003319 supportive effect Effects 0.000 claims description 2
- 239000013615 primer Substances 0.000 description 84
- 239000000123 paper Substances 0.000 description 40
- 239000002585 base Substances 0.000 description 18
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 12
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 12
- 238000011534 incubation Methods 0.000 description 12
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 12
- 235000013305 food Nutrition 0.000 description 10
- 239000008188 pellet Substances 0.000 description 9
- 239000011543 agarose gel Substances 0.000 description 8
- 239000003139 biocide Substances 0.000 description 7
- 238000011109 contamination Methods 0.000 description 7
- 241000894007 species Species 0.000 description 7
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 6
- 229930024421 Adenine Natural products 0.000 description 6
- 241000193468 Clostridium perfringens Species 0.000 description 6
- 229960000643 adenine Drugs 0.000 description 6
- 229940104302 cytosine Drugs 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 239000002987 primer (paints) Substances 0.000 description 6
- 229940113082 thymine Drugs 0.000 description 6
- 238000000137 annealing Methods 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 5
- 239000008223 sterile water Substances 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 239000007102 tryptic soy broth medium Substances 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000002655 kraft paper Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 241000193388 Bacillus thuringiensis Species 0.000 description 3
- 241000193459 Moorella thermoacetica Species 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 229940097012 bacillus thuringiensis Drugs 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- -1 fecal matter Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 2
- 241000006378 Bacillus cereus group Species 0.000 description 2
- 241000006381 Bacillus flexus Species 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 241000202341 Bacillus sporothermodurans Species 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 241000193764 Brevibacillus brevis Species 0.000 description 2
- 241000193171 Clostridium butyricum Species 0.000 description 2
- 241000193167 Clostridium cochlearium Species 0.000 description 2
- 241000186587 Clostridium scatologenes Species 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 2
- 241000186544 Moorella thermoautotrophica Species 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000193465 Paeniclostridium sordellii Species 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 241000132152 Polymyxa Species 0.000 description 2
- 241000186567 Romboutsia lituseburensis Species 0.000 description 2
- 241000193448 Ruminiclostridium thermocellum Species 0.000 description 2
- 241000204376 Sporomusa ovata Species 0.000 description 2
- 241001147775 Thermoanaerobacter brockii Species 0.000 description 2
- 241000520824 Thermobrachium celere Species 0.000 description 2
- 241000589500 Thermus aquaticus Species 0.000 description 2
- 241000193453 [Clostridium] cellulolyticum Species 0.000 description 2
- 241001147800 [Clostridium] paradoxum Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 1
- 101150076489 B gene Proteins 0.000 description 1
- 101100224392 Bacillus subtilis (strain 168) dpaA gene Proteins 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000193157 Paraclostridium bifermentans Species 0.000 description 1
- 241001074085 Scophthalmus aquosus Species 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002623 sporogenic effect Effects 0.000 description 1
- 101150003658 ssp gene Proteins 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
DETECTION OF SPORE FORMING BACTERIA
This invention relates to methods for the detection of spore forming bacteria.
The invention is particularly useful in detecting bacteria in paper products and paper . manufacturing streams. Detection of spore forming bacteria according to the present invention includes methods involving polymerase chain reaction. Primers particularly suitable for use in detection of spore forming bacteria are disclosed as well.
Paper products used in the packaging of food should be free from the presence of microorganisms which adversely affect the hygiene of the food. The most common route of contamination by these microorganisms is during the manufacturing of the paper products, where the microorganisms can grow and flourish. Commonly, such contamination is dealt with through the use of biocides or heat. However, biocide usage may be limited by risks at both the paper mill, and in the final paper product.
Additionally, some microorganisms are able to avoid eradication by their inherent protection mechanism - sporulation.
In the paper industry, one of the more costly and persistent problems is control of spore forming bacteria (SFB). Unlike most bacteria, SFB can pass through dryer sections of a mill to pose a contamination threat when the paper product is used, for example, in food packaging. Also, spore forming bacteria are frequently resistant to all but the most toxic of biocides. A number of SFB have been identified as problematic in papermaking, and have been described by Pirttijirvi and others in Journal of Applied
Bacteriology 81, 445-458 (1996), the entire contents of which are hereby incorporated by reference.
A number of industry trends have generated even more concern over the microbiological quality of paper used for food packaging. Recycled fiber which often contains starch and coating material can support microbial growth. As the fraction of recycled material going into production increases, so will the chance for contamination . of the finished product. Coinciding with this increase in recycled fiber is a desire to decrease the use of biocides for control of microbial growth. Fast, reliable, simple and cost-effective monitoring of product quality will increase overall production efficiency : L :
by allowing problematic populations to be controlled while at the same time permitting biocides to be applied when, and at the specific location needed.
The current industry standard for food packaging grade material in the United
States is 250 spores per gram of paper. This is determined by the Dairyman’s method, a plate count enumeration technique which requires a 48-hour incubation period. A more . rapid diagnosis of a contamination problem would result in significantly less wasted product and an overall increase in mill productivity.
The need to rapidly detect spore forming bacteria is not limited to paper making processes. For example, the heat resistant spores formed by members of Bacillus,
Paenbacillus, and Clostridium, for example, can be problematic in food, pharmaceutical, and medical product processing, where heat sterilization under pressure is not appropriate. In these processes, special care must be taken to avoid contamination and to evaluate sources of contamination when present. A rapid identification of a contaminating source material can often prevent unnecessary production stoppages, and may save thousands of dollars.
The need to identify spore forming bacteria also arises in medical treatment.
Occasionally, for example, in the treatment of a bacterial infection, e.g., bronchitis, upper respluatory tract infection, earache, etc., the antibiotic selected is effective against the organism causing the infection but fails to kill a population of bacteria such as a
Clostridium strain (a spore forming bacteria). While the Clostridium is normally not problematic, in the absence of competition from other organisms (which are killed by the original course of antibiotics), the Clostridium thrives, causing a potentially serious infection. Thus, there is a need for detecting the presence of such species in a biological sample.
The present invention is directed to methods for detecting the presence of bacteria. . +7 More particularly, the present invention is directed to methods for detecting the presence of bacteria using nucleotide primers and probes. . In particular, the present invention is directed to detecting spore forming bacteria with such primers. Detection methods according to the present invention include the use of polymerase chain reaction in conjunction with electrophoresis, or fluorescence techniques.
The present invention is further directed to nucleotide primers, and more particularly, to sets of nucleotide primers, which are used in the detection of spore © 5 forming bacteria, . These and other aspects of the present invention are achieved by the provision of methods for the systematic identification of sporulation genes in spore forming bacteria comprising amplifying a portion of a gene from total cellular DNA of the spore forming bacteria by using a primer group comprising 5 -AGTATCATTCATGAAATTGG-3 (SEQ ID NO. 1), 5 -AAAAAAGCAGTTGACT-3 (SEQ ID NO. 2), 5 -
CGGCTTGCCGTTGTATT-3 (SEQ ID NO. 3), 5 -GAAGATGTGACGAAAAAG- 3 (SEQ ID NO. 4), 5 -CAAGAAGATGTGACGAAA-3 (SEQ ID NO. 5), 5 -
GTTGTATTATATTTCTTTGC-3 (SEQ ID NO. 6), and 5 -
GTTGTGTTAAATTTTTTGGC-3 (SEQ- ID NO. 7), and 5 -
AGTATCATTCATGAAATTGGCGTTCC-3 (SEQ ID NO. 8); and detecting the presence of the amplification product. Spore forming bacteria include, but are not limited to, Bacillus megaterium, Bacillus lichenformis, Bacillus cereus group, Bacillus pumilus, as well as Paenbacillus macerans, Paenbacillus polymyxa, Paenbacillus pabuli,
Bacillus flexus, Bacillus subtilis, Bacillus anthracis, Bacillus sporothermodurans,
Bacillus sphaericus, Clostridium perfringens, Clostridium butyricum, Clostridium pasteurianum, Clostridium cochlearium, Clostridium scatologenes, Clostridium sordellii, Clostridium lituseburense, Clostridium paradoxum, Clostridium thermocellum,
Thermoanaerobacter brockii, Moorella thermoautotrophica, Sporomusa ovata,
Thermobrachium celere, Bacillus acidocaldarus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus thuringiensis, Bacillus stearothermophilus, Clostridium dificile,
Clostridium cellulolyticum, Clostridium bifermentans, and Clostridium acetoburylicum.
Amplifying may include the use of polymerase chain reaction, and detecting may include electrophoresing the amplification product and visualizing an electrophoresis substrate . with staining. In some embodiments, the electrophoresis substrate comprises agarose gel; in some embodiments, staining comprises applying ethidium bromide. . Another aspect of the present invention includes a primer pair comprising a member selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID
NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO.
8, and another aspect of the present invention includes a nucleotide sequence, which may be a primer or probe, comprising a sequence selected from the group consisting of SEQ
ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8. The present invention also includes primers selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, . SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
The present invention is still further directed to a composition comprising at least one cellulose-containing material and at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID
NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8. The cellulose-containing material may comprise paper pulp.
Also within the scope of the present invention are kits for testing for the presence of spore forming bacteria, wherein the kits comprise at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID
NO. 3, SEQ ID NO. 4, SEQ ID NO. §, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8, and at least one media supportive of spore forming bacterial growth. The kits may be designed for use in testing paper-making processes, or may be generic to testing any material. Methods of using such kits are also within the scope of the present invention.
The present invention is still further directed to methods for testing a sample for the presence of spore forming bacteria. One method comprises a) combining at least two nucleotide primers with a sample, wherein said nucleotide primers i) are complimentary to at least one forward and at least one reverse nucleic acid sequence from the total cellular DNA of the bacteria, ii) are able to hybridize spoOA4 gene conserved regions of spore forming bacteria, but not those of non-spore forming bacteria, and iii) are such that amplification of a portion of the spoOA gene from cellular DNA of such spore forming bacteria using such primers results in the generation of a 346-365 nucleotide long DNA product; b) amplifying cellular DNA of bacteria in the sample with primers; and ¢) detecting the presence of amplified DNA. The sample may be a cellulose-containing . sample and may be a sample taken from a paper making process. Such samples include, but are not limited to, samples from white water, head box, broke, additive storage tank, . and coated calender. Other samples include air, soil, water, blood, fecal matter, starch, protein, or an epichlorohydrin reaction product. Any of the nucleotide sequences disclosed in the present application may be used for the primer pairs, and such sequences include SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5,
SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
The present invention also provides methods for testing cellulose-containing samples for the presence of spore forming bacteria, wherein the methods comprise combining at least one primer comprising a sequence selected from the group consisting . of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ
ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8 with a cellulose-containing sample. The present invention is also directed to methods for testing a cellulose-containing sample for the presence of spore forming bacteria. One such method comprises a) combining at least two nucleic acid primers of the invention, complimentary to at least one forward and at least one reverse nucleic acid sequence from the total cellular DNA of the bacteria with a cellulose-containing sample; and b) visualizing hybridized primers. The at least two nucleic acid primers preferably comprise at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and
SEQIDNO. 8.
The present invention also provides methods for controlling a population of spore forming bacteria in an industrial process stream, the methods comprising a) detecting bacteria in the process stream using a primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ
ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8; and b) adjusting a biocide concentration in the process stream sufficient to reduce the number of bacteria. The industrial process stream may be, for example, a paper making process stream, or a food processing stream.
Other aspects of the present invention include methods for the systematic identification of sporulation genes in spore forming bacteria, the methods comprising: a) amplifying a portion of a gene from total cellular DNA of the spore forming bacteria by using at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ
ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8; and b) detecting the presence of an amplification product. ) 30 In another aspect, this invention provides a probe for detecting the presence of . spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with highly conserved regions of the spo04 gene of the spore forming bacteria Bacillus and Clostridium bacteria species set out in either (a) or (b) below: a) Bacillus cereus, Bacillus megaterium, Bacillus anthracis, and Clostridium pasteurianuni; b) Bacillus cereus, Bacillus megaterium, Bacillus sphaericus, and . Clostridium pasteurianum, said nucleic acid sequence being unable to form a detectable hybrid with genetic material of non-spore forming bacteria. Preferred highly conserved regions of the spore forming bacterium species set out in (a) and (b) are those shown in Table II and Table III of
Example 2 herein below. Preferred probes of this aspect of the invention are those wherein amplification of a portion of the spoOA gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product. Additional preferred Bacillus and Clostridium bacteria species for (a) above are
Bacillus subtilis and Clostridium thermoaceticum. Additional preferred Bacillus and
Clostridium bacteria species for (b) above are Bacillus stearothermophilus and
Clostridium thermoaceticum. Preferred highly conserved regions for these species are also set out in Tables II and III of Example 2 herein below.
In another aspect, this invention provides a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with highly conserved regions of the spo0A gene of the spore forming bacteria Bacillus and Clostridium bacteria species set out in either (a) or (b) below: a) Bacillus cereus, Bacillus megaterium, Bacillus subtilis, and
Clostridium pasteurianum, b) Bacillus cereus, Bacillus megaterium, Bacillus sphaericus, and
Clostridium pasteurianum, said nucleic acid sequence being unable to form a detectable hybrid with genetic material ] of non-spore forming bacteria. Preferred highly conserved regions of the spore forming bacterium species set out in (a) and (b) are those shown in Table VI and Table VII of . Example 3 herein below. Preferred probes of this aspect of the invention are those wherein amplification of a portion of the spoOA gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product. Additional preferred Bacillus and Clostridium bacteria species for both (a) and (b) above are Bacillus thuringiensis and Clostridium thermoaceticum. Preferred highly conserved regions of these species are those set out in Tables VI and VII of Example 3 herein below. . The present invention also provides probes for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with spo04 gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence consists essentially of adenine, guanine, cytosine, and thymine.
Such nucleotide sequences may comprise SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3,
SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, or SEQ ID NO. 8.
Another embodiment of the present invention is a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with spo04 gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 76 to 93 of the spo0A4 gene of Bacillus cereus, corresponding to GenBank accession number gb
U09972. This nucleotide sequence may comprise SEQ ID NO. 4 and SEQ ID NO. 5.
The present invention also provides a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with spo0A4 gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 403 to 422 of the spo0A gene of Bacillus cereus, corresponding to GenBank accession number gb U09972. The nucleotide sequence may comprise SEQ ID NO. 3, SEQ ID NO.6 or SEQ ID NO. 7.
The present invention is also directed to compositions comprising at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ
ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8. The composition may also include a cellulose-containing 3 material, such as paper pulp.
Aspects of the present invention include methods for testing samples for the presence of spore forming bacteria, the methods comprising a) combining a tagged or -7- B labeled probe of the invention with a sample, b) hybridizing the tagged or labeled probe to the target spore forming bacteria spoOA gene, and c) detecting the hybridized product.
SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID
NO. 6, SEQ ID NO. 7, or SEQ ID NO. 8 may used as tagged or labeled probes. Samples which may be tested include, but are not limited to, samples of air, soil, water, blood, . fecal matter, starch, protein, and/or an epichlorohydrin reaction product.
Another aspect of the present invention includes probes for detecting the presence of spore forming bacteria in a sample, the probes comprising a nucleotide sequence able to form a detectable hybrid with spo04 gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 70 to 427 of the spo0A gene of Bacillus cereus, the nucleotide sequence consisting essentially of guanine, cytosine, adenine, and thymine.
Another aspect of the present invention includes probes for detecting the presence of spore forming bacteria in a sample, the probes comprising a nucleotide sequence able to form a detectable hybrid with spo0A gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 70 to 427 of the spo0A gene of Bacillus cereus, or to bases 570 to nucleotide 930 of the spo0A gene of
Bacillus subtilis (gb M10082). Such nucleotide sequence preferably comprise at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5,
SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
Preferred probes of the foregoing aspects of the invention are those wherein amplification of a portion of the spoO4 gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product.
Another aspect of the present invention includes methods of making nucleotide sequences for detecting the presence of a conserved gene in spore forming bacteria, the } methods comprising a) determining conserved regions of the conserved gene from at least two strains of spore forming bacteria; and b) preparing nucleotide sequences able to . hybridize to the conserved regions, wherein the nucleotide sequences consist essentially of adenine, guanine, cytosine, and thymine. The conserved gene may comprise spo04, ssp, and/or dpaA/B, but is preferably spo0A.
The present invention is also directed to systems for identifying spore forming bacteria, the systems comprising: a) means for rendering DNA of the spore forming bacteria susceptible to hybridization with at least one nucleotide primer; b) at least one nucleotide primer; and c) means for detecting the hybridization of the DNA of the spore forming bacteria to the at least one nucleotide primer. The DNA of the spore forming ] bacteria may comprise the spo04 gene, and the at least one nucleotide primer may consist essentially of adenine, guanine, cytosine, and thymine. The at least one nucleotide primer may comprise a sequence selected from the group consisting of SEQ
ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8. The means for rendering DNA of the spore forming bacteria susceptible to hybridization may comprise a growth step in which the bacteria are placed in an environment which encourages growth, followed by a lysis step in which the bacteria are lysed. The lysis step may comprise heating. The means for detecting the hybridization may comprise polymerase chain reaction. The means for detecting the hybridization may comprise a fluorescence detection technique.
The present invention is directed to methods for detecting bacteria, and in particular, spore forming bacteria (SFB). Spore forming bacteria are those bacteria which bave the ability to form spores, and such bacteria are well known in the art.
Examples of such SFB include, but are not limited to, Bacillus megaterium, Bacillus lichenformis, Bacillus cereus group, Bacillus pumilus, as well as Paenbacillus macerans,
Paenbacillus polymyxa, Paenbacillus pabuli, Bacillus flexus, Bacillus subtilis, Bacillus anthracis, Bacillus sporothermodurans, Bacillus sphaericus, Clostridium perfringens,
Clostridium butyricum, Clostridium pasteurianum, Clostridium cochlearium,
Clostridium scatologenes, Clostridium sordellii, Clostridium lituseburense, Clostridium paradoxum, Clostridium thermocellum, Thermoanaerobacter brockii, Moorella thermoautotrophica, Sporomusa ovata, Thermobrachium celere, Bacillus acidocaldarus,
Bacillus amyloliquefaciens, Bacillus brevis, Bacillus thuringiensis, Bacillus ’ 30 stearothermophilus, Clostridium dificile, Clostridium cellulolyticum, Clostridium . bifermentans, and Clostridium acetoburylicum.
The present invention is useful in the detection of SFB in paper making processes, but is not limited to such processes. (As used herein, the term “paper” is to be used in the generic sense. That is, “paper,” as in a “paper making process,” is meant to include paper, paperboard, cardboard, etc.) When used for testing in paper making processes, the process water itself may be tested. The process water may be tested anywhere in the process, but is preferably tested in head boxes or storage tanks. Such storage tanks may contain paper making additives which are to be tested for the presence of SFB. Such additives include starch, latex, clays, proteins, and epichlorohydrin reaction products, including but not limited to reaction products of poly(adipic acid-co- diethylenetriamine) and epichlorohydrin, sold under the trade name Kimene. In addition to testing process water in the paper making process, the paper making machine may be tested for the presence of SFB. Frequently, it is preferable to test shower head deposits for the presence of SFB.
The present invention may also be used in detecting SFB in air, soil, food, and water, including waste water, industrial process water, and drinking water. The present invention may be used in the detection of SFB in protein-containing samples. The present invention may be used in the detection of SFB in medical diagnostic applications, including, for example, testing for at least one SFB in blood or fecal matter.
The methods for detecting bacteria in these other media are similar to those for detection in paper making, as described herein.
The present invention focuses on the evolutionary conservation of genes mediating the process of sporulation. A subset of phylogenetically diverse bacteria are able to form spores. Most commonly found spore forming bacteria are members of the genus Bacillus (aerobic bacteria) and Clostridium (anaerobic bacteria). Sporulation is a complicated developmental process, responsive to adverse environmental conditions and under strict physiological control of the cell. Heat, starvation, and chemical perturbation include some but not all of the factors that may induce the sporulation pathway. Genes involved early in the sporulation process are highly homologous across species boundaries. Spo0A4, one such gene, may be considered a “master switch” in the sporulation process.
The spo0A gene encodes a kinase responsible for signaling, via phosphorylation, other genes in the process to become active. The phosphorylation state of the spo0A . kinase dictates its activity in the cell. Due to this central role in triggering sporulation, spo04 is a highly conserved gene and hence a good target gene for detection.
The present invention is based on the discovery that spore forming bacteria have some conserved genetic material that may be targeted in their detection. The conserved genetic material targeted in accordance with the present invention is the spo04 gene, or a gene homologous thereto. By targeting this gene (or a homologous gene), the present invention is able to detect a very broad range of bacteria. Each of the bacteria detectable according to the present invention is believed to have the spo0A gene, or a gene homologous thereto, which may be involved in sporulation. Other genes which may be targeted in accordance with the present invention include the ssp gene and the dpad/B gene, each of which is present in sporogenic bacteria and absent in asporogenic bacteria.
The concept underlying the present invention is the discovery that specific, short chains of nucleotides, can bind to the genetic material of the targeted bacteria. Through a number of different techniques, this binding can be visualized or even quantified. The basic underlying technology of the use of nucleic acid probes, or primers, to identify target genetic material is well known in the art, and has been described elsewhere. For their discussion of spore forming bacteria, and methods for their detection using the spo0A gene, Brill and Wiegel (Journal of Microbiological Methods 31 (1997) 29-36), and Brown et al. (Molecular Microbiology 14(3) (1994) 411-426), are hereby incorporated by reference. For their discussion of the use of probes and primers for identifying bacteria, U.S. Patent Nos. 5,747,252, 5,969,122, 5,430,137, 5,714,321, and 5,958,679, are hereby incorporated by reference.
Thus, the present invention is directed to the use of nucleotide sequences for targeting specific portions of the spo04 gene. These nucleotide sequences can bind, or hybridize, to target portions of the SFB genetic material. The target portion of the spo0A4 gene spans bases beginning at about 70 and ending at about 427 of Bacillus cereus,
GenBank accession #gb U09972. The nucleotide sequences of the present invention can also target homologous sequences from other SFB.
Obviously, the numbering of the bases will differ from strain to strain. However, using the CLUSTAL alignment program (Baylor College of Medicine Nucleotide Search
Launcher) to search for homologous sequences in the GenBank database, one of skill in the art can easily determine other SFB, and their corresponding genetic material. (Of course, other alignment programs may be used.) By way of non-limiting example,
Bacillus subtilis (gb M10082) would be targeted at nucleotide 570 to nucleotide 930.
The polymerase chain reaction (PCR) is one technology which may be used to visualize the presence of sporulation genes. This method is based on the base complimentarity of DNA. DNA is composed of two anti-parallel strands composed of nucleotide “bases.” These bases, adenine, guanine, cytosine and thymine, form specific hydrogen bonds with one another. Adenine pairs with thymine and guanine pairs with . cytosine. Strands of DNA can be denatured or converted to a single strand form by alkali or heat treatment. When conditions are favorable DNA will reassociate to its double stranded conformation.
The polymerase chain reaction (Mullis, U. S. Pat. Nos. 4,683,195, 4,683,202, and 4,800,159, the entire contents of each of which is incorporated by reference) is a commonly used method to amplify target DNA segments to detectable levels. It is currently being employed to detect many pathogenic bacteria. In this process, DNA primers of specific sequence, complementary to flanking regions of the target area, are used to prime enzymatic synthesis of DNA using a DNA polymerase. DNA polymerase requires a primer to initiate synthesis of a complementary DNA strand.
A number of different types of apparatuses and systems are available for performing PCR. Common apparatuses include Mini Cycler (MJ Instruments), Delta
Cycler I System (EriComp), and Smart Cycler (Cepheid). Other systems may be used in accordance with the present invention as well. Examples are described in U.S. Patent
Nos. 5,882,496, 5,674,742, 5,646,039, 5,589,136, 5,639,423, each to NORTHRUP et al., 5,527,510, to ATWOOD et al., and 5,958,349, to PETERSEN et al. For their discussion of PCR systems, U.S. Patent Nos. 5,882,496, 5,674,742, 5,646,039, 5,589,136, 5,639,423, each to NORTHRUP et al., 5,527,510, to ATWOOD et al., and 5,958,349, to )
PETERSEN et al. are incorporated herein by reference.
Primers are short (usually about 15-22 bases) stretches of nucleotides. Priming during PCR is controlled at the annealing step by temperature. Annealing conditions are experimentally determined for each primer set to allow for specificity. Following annealing, polymerization occurs as the polymerase synthesizes a complementary DNA } strand. After polymerization, the PCR reaction is heated to denature all double stranded
DNA. The use of a thermostable DNA polymerase, isolated from the hyperthermophile . Thermus aquaticus, allows for repeated cycles of annealing, polymerization and denaturing to occur without loss of enzymatic activity. The process of PCR amplification is a routine laboratory process carried out in automated thermocyling units.
The result is an exponential amplification of the targeted DNA segment. The amplified target may then be detected. Preferred primers, primer pairs and primer sets of the invention are those wherein such amplification results in the generation of a detectable 346-365 nucleotide long DNA product. The nucleotide sequences of the present invention, including SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ
A ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8., may be used in primers.
One method for detecting the presence of the amplified product is agarose gel electrophoresis, followed by staining. Other detection methods include, but are not limited to, fluorescence detection techniques. In one fluorescence-based technique, an intercalating dye such as Syber Green or ethidium bromide binds to double stranded
DNA and then fluoresces. Incorporation of these dyes into PCR reactions result in an increase in fluorescence as the PCR reaction proceeds and double stranded DNA is synthesized. Thermal denaturation of the generated products can be used to ascertain the size and %GC (%GC is the number of G or C bases divided by the total number of bases) content of the PCR products generated.
One commercially available PCR based fluorescent detection system is the
TagMan™ system. Examples of reporter dyes for this system are 6-carboxyfluorescein (FAM), tetra-6-carboxyfluorescein (TET), and hexachloro-6-carboxyfluorescein (HEX).
See P. M. Holland, R. D. Abramson, R. Watson, S. Will, R. K. Sakai and D. H. Gelfand, 1992. Detection of specific polymerase chain reactions product by utilizing the 5°-3’ exonuclease activity of Thermus aquaticus DNA polymerase. Clin. Chem., 38:462-463.
Another commercially available detection system uses molecular beacons. See S. Tayagi and F. R. Kramer, 1996. Molecular Beacons: Probes that fluoresce upon hybridization.
Nature Biotechnology 14:303-308.
In another technique, a tagged or labeled nucleotide sequence is used to detect hybridization. For example, a fluorescently tagged oligonucleotide sequence derived from an internal region of the spo04 PCR product can be used to detect the presence of the target in samples. As the PCR reaction proceeds the fluorescent tag is cleaved from the probe and fluorescence is observed. Increasing fluorescence is directly correlated with increased target in the test sample. Two examples of such sequences are 5 - } AGTATCATTCATGAAATTGG-3 (SEQ ID NO. 1) and 5 -
AGTATCATTCATGAAATTGGCGTTCC-3 (SEQ ID NO. 8). These sequences are presented for illustrative purposes; other stretches of conserved sequences within spo04 may also be targeted, Other nucleotide sequences of the present invention, including
SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, and SEQ
ID NO. 7 would be useful in this regard.
Detection of hybridization between the nucleotide sequences of the present invention and the target may be achieved in a number of manners, in addition to those ) already mentioned. Especially included in such other methods are those not requiring a polymerase chain reaction or primer pair to obtain a detectable hybrid. For example, it is envisioned that the nucleotide sequences of the present invention may be tagged or labeled and used to detect the target sequences using oligonucleotide probing. The sequences could be tagged or labeled with a fluorescent or radioactive molecule. In the : case of fluorescent labeling, the hybridized nucleotide sequence emits a different energy spectra than in non-hybridized form, which is detected by means well known in the art.
With the radioactive probe, the hybridized sequence may be detected by autoradiography using exposure to a radiation-susceptible film. See Maniatis, T., E. F Fritsch and J, ]
Sambrook. 1982 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor
Laboratories, Cold Spring Harbor, New York. The nucleotide sequences of the present ; invention, including SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQID NO. 4, SEQ
ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8, are useful in this regard as probes. :
The nucleotide sequences of the present invention were generated by sequence comparison of the spo0d gene from a broad spectrum of spore forming bacteria. This : process entailed using a nucleic acid sequence alignment software program to elucidate highly conserved regions of the gene. From these regions, specific priming sites were i chosen and appropriate primers were synthesized. Determination of the optimal } sequences for primer selection is done by trial and error. Preferred primers meet all of ; the following criteria; 1 detection of spo0d from a characterized set of spore forming bacteria; J ii. negative results when testing non-SFB; and iii. detection of spo0d from uncharacterized spore forming bacteria isolated from paper or paper manufacture samples.
It should be noted that the inventive nucleotide sequences disclosed herein are selected based on their ability to hybridize target genes of SFB. In particular, the instant : -14- iE
HE —
nucleotide sequences are directed at conserved target genetic material of SFB. In considering which sequences will target the SFB, the instant nucleotide sequences of the present invention should be considered highly preferred. However, it is recognized that absolute identity to the sequences of the present invention may not be necessary to achieve a satisfactory result. That is, it is recognized that substitution of one or more } bases may still allow hybridization to the target genes of SFB. Identity to the instant sequences is most preferred, and homologous or conservative substitutions are less preferred, but may still be acceptable. The trade-off will likely be a lower level of “inclusiveness,” that is, fewer species of SFB will be identified by the sequences in which substitutions have been made. In some applications, e.g., where identification of only one species of SFB is needed, this lower level of inclusiveness may be acceptable.
The methods of the present invention have been optimized to provide for detection of spore forming bacteria. In accordance with the present invention, spores may be detected at levels as low as 200 spores per gram of paper (and possibly even lower). The following steps allow for optimal detection: a. 10 ml of 1% pulp sample (1 g pulp in 100 ml sterile water) is combined with 40 ml of tryptic soy broth medium (Difco Laboratories) and placed at 37 C for 7 hours. b. 4 ml of this sample are spun down to a pellet in a microcentrifuge tube. vc The centrifuged pellet is washed in 100 pl sterile water (deionized) and centrifuged again. d. The pellet is resuspended in 30 pl sterile water and boiled for 5 minutes. e. 5 pl of the boiled solution is used for PCR and results are visualized on an agarose gel.
Note that a shorter incubation time in step a) may be used where there are higher concentrations of SFB. Also, some samples may require an even longer incubation period in step a). For example, a 16-hour incubation period may be used (but only 1 ml of the sample is centrifuged in step b) for samples that are problematic. For example, longer incubation times may be used where very low numbers of SFB are believed present, or if a PCR amplification inhibitor is present. Thus, with a longer incubation period, detection to levels as low as approximately 100 spores/g paper may be achieved.
Additionally, in step a), a process water, additive, or stock sample may be used instead of pulp as the starting sample. In step e), other visualization methods, e.g., fluorescence methods, may be used.
Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The following preferred specific embodiments are, therefore, to be construed as merely illustrative, and . not limitative of the remainder of the disclosure in any way whatsoever.
The entire disclosures of all patents and publications, cited above and below, are hereby incorporated by reference as though set forth in full herein.
The following examples further illustrate the practice of the invention and should not be construed as limiting.
EXAMPLE 1 - PRIMER SET NUMBER 1
A set of spo04 sequences is accessed through GenBank and aligned using the
CLUSTAL alignment program. From the sequence alignment, oligonucleotide priming sites are selected and a preliminary primer set is chosen. A forward primer, 5 -
AAAAAAGCAGTTGACT-3 (SEQ ID NO. 2), and a reverse primer, 5 -
CGGCTTGCCGTTGTATT-3 (SEQ ID NO. 3), are synthesized. PCR products using this primer set are expected to be in the range of about 300 to 400 base pairs.—PCR reaction conditions are optimized using “Ready to Go” PCR beads (Pharmacia
Biotech, Piscataway, N.J.) and different annealing temperatures for the thermocycling program. Any PCR apparatus may be used for this step, and the Mini Cycler and Delta
Cycler are non-limiting examples thereof. Characterized SFB, as well as a set of uncharacterized SFB, isolated from a paper mill, are included in this test.
Uncharacterized samples (samples from a paper mill) testing positive are later tested and are shown to be positive for the presence of the spo0A4 gene. The results from the characterized SFB are shown in TABLE I.
TABLE I
The results show that all SFB except Clostridium perfringens showed a band with molecular weight size just under about 369 base pairs. To confirm that spo0A is being targeted, the agarose gel from the PCR is Southern blotted to nylon. As predicted, all
SFB except Clostridium perfringens hybridized labeled amplification products from
Bacillus cereus. However, even though Clostridium perfringens was not detected using . this primer set, the positive results from uncharacterized paper mill samples indicate that this primer set is useful for its intended purpose.
EXAMPLE 2 - PRIMER SET NUMBER 2
Based on the results of Example 1, above, a second primer set is generated by comparison against a larger data set. TABLE II shows the data considered for the forward primer and TABLE III the data for the reverse primer of the refined primer set.
TABLE II
TABLE III
As can be seen from TABLES II and III, there is considerable sequence identity and homology in the genetic material of the SFB. Using the information from the sequence alignment, a new forward primer, 5 -GAAGATGTGACGAAAAAG-3 (S EQ ID NO. 4) is synthesized. This primer, together with 5 -CGGCTTGCCGTTGTATT-3 (SEQ
ID NO. 3), described in Example 1 above, comprise the new primer set.
This primer set (SEQ ID NOS. 4 and 3) is tested individually against known SFB and non-SFB. This primer set yields spo0A4 products from characterized SFB and no products from non-SFB. Positive results are indicated by the presence of a band of 346- 365 base pairs in size on an agarose gel, following PCR. TABLE IV shows the results from the characterized SFB which are tested.
TABLE IV
Surblocors ares
Salome dermis
Er a
Webselapemonize
As can be seen from TABLE IV, Clostridium perfringens, in addition to the other species, is detected using the new primer set. As can be seen from the results, this primer set exhibited the desired characteristics: hybridization to SFB, and no ’ 5 hybridization to non-SFB. Also, as with the previous primer set (from Example 1), positive results from uncharacterized paper mill samples confirms that this primer set works for its intended purpose.
Once it is determined that the primer set did perform its intended function, additional tests are performed to determine how sensitive the primer set is. The following procedure is therefore performed to determine the “detection limits” for the primer set. Although this procedure used paper samples as test materials, the procedure is adaptable to testing all manners of samples, including air, soil, food, and water, including but not limited to, waste water, industrial process water, and drinking water. It should be noted that in Example 3, below, this procedure is further refined and optimized.
Determining Detection Limits 1. A 100 ml culture of Bacillus cereus is grown to lag phase and then placed at 80 C to induce sporulation. 2. This culture is diluted in 10-fold increments in phosphate buffered saline and 0.1 ml of the dilutions are spotted onto 0.5 g paper samples of different types and grades including A) Kraft liner board, recycled, B) alkaline kraft paper, and C) acid fine paper. 3. Paper samples are then placed in 10 ml phosphate buffered saline (PBS) and vortexed for 2 minutes. 4. The samples are then placed at 80 C for 10 minutes and 1 (one) ml of the sample is placed into 9 ml PBS to obtain another 10-fold dilution. 5. 0.1 ml of the sample is added to a sterile microfuge tube containing 0.1 ml tryptic soy medium (0.1 ml of the sample and sample dilution are plated to correlate PCR result with colony forming units). 6. The samples are incubated at 37 C for 45 minutes to allow for germination. [Note: this step is optimized in Example 3. A longer incubation time may be necessary for lower bacterial concentrations.] 7. The microfuge tubes are boiled for 5 minutes and 5 pl are used for PCR using “Ready to Go” PCR beads (Pharmacia).
8. The thermocycler program is set as follows: a. 5 minutes at 94 C b. 30 cycles of: 0.5 minutes at 94 C, 0.5 } minutes at 52 C, 0.5 minutes at 72 C
Cc. 3 minutes at 72 C ; The detection limits established for this primer set are set forth in TABLE V.
TABLE V
Sample | Sporesosgtape? | spot POR brotue_ nopger | omrl0 [0 - oa | asses [0-0]
B | sexe0 | +
B | 70-0
TC sews * determined from plate counts * broth culture of Bacillus cereus spores, no paper present
In TABLE V, A is kraft liner board, recycled, B is alkaline kraft paper, and C is acid fine paper.
EXAMPLE 3 - PRIMER SET NUMBER 3
The primer set from Example 2 may inconsistently detect Bacillus sphaericus. In order to address this problem, a new primer set is prepared. The data considered in preparing the refined primer set is shown in TABLE VI (forward primer) and in TABLE
VII (reverse primers).
TABLE VI
TABLE VII
Coser papingers_[6[¢] | [A[G[G[C|A|T[S|C|A[A[G[ [S| T[T] > Using the information from the sequence alignment, a new primer set is prepared. The new set comprises one forward primer and two reverse primers. The new set is: 5 -
CAAGAAGATGTGACGAAA-3 (SEQID NO. 5) (forward), 5 -
GTTGTATTATATTTCTTTGC-3 (SEQ ID NO. 6) (reverse), and 5 -
GTTGTGTTAAATTTTTTGGC-3 (SEQ ID NO. 7) (reverse).
This primer set yields spo04 products from characterized SFB and no products from non-SFB. Positive results are indicated by the presence of a band of 347-356 base pairs in size on an agarose gel, following PCR. TABLE VIII shows the results from the characterized SFB which are tested.
TABLE VIII
EC
A
Ee
Poston sergio
Fb emias *Non-SFB
Once it is determined that the new primer set performed as intended, tests are preformed to determine the limits of detection. The procedure for determining the limits of detection is similar to that in Example 2 above, with some exceptions. 1. 10 ml of 1% pulp sample (food-grade packaging board) is combined with 40 ml tryptic soy broth medium and placed at 37 C for 7 hours. 2. 4 ml of sample are centrifuged to a pellet in a microcentrifuge tube. 3. The pellet is washed in 100 pl sterile water and centrifuged again. 4. The pellet is resuspended in 30 pl sterile water and boiled for 5 minutes. 5. 5 pl of the boiled solution is used in the polymerase chain reaction.
As noted above, some samples may require incubation time as long as 16 hours to optimize detection. (Longer periods are believed to be needed when the sample has a high concentration of clay, or other contaminant.) When a 16-hour incubation is employed, only 1 ml of sample is pelleted. The longer period may improve detection to aslow as 100 spores/g paper.
The detection limits determined for the Example 3 primer set are shown in
TABLE IX below.
TABLE IX
Sample | Sporsiose Paper’ | spol POR Product? _
I ET
IL ET
IL = EE * determined from plate counts
In TABLE IX, samples A-F are all food-grade packaging board samples of the same type, spiked with different levels of SFB.
EXAMPLE 4 - DETECTING SPORE FORMING BACTERIA IN PAPER MAKING
PROCESS
Samples of 10 ml are taken from process water in the head box area of the paper mill. The samples are separately mixed with 40 ml tryptic soy broth medium. Following a 7-hour incubation period, samples are centrifuged to concentrate bacterial contents.
The supernatant is decanted and the pellet resuspended.
The resuspended sample is boiled to lyse the bacteria, and the lysed sample cooled and mixed with primers prior to placing the test mixture in a PCR thermocycler.
The thermocycler is run and the PCR results are electrophoresed on an agarose gel, 3 stained with ethydium bromide, and visualized under an ultraviolet light.
If spore forming bacterial counts are shown to be unacceptably high, biocide is : 25 added to kill the bacteria.
EXAMPLE 5 — DETECTING SPORE FORMING BACTERIA IN A FOOD MAKING
PROCESS
Samples of 10 ml are taken from milk being processed both prior to, and after, pasteurization. Samples are also periodically checked in the packaged product as well.
Each 10ml sample to be tested is separately mixed with 40 ml tryptic soy broth medium.
Following a 7-hour incubation period, samples are centrifuged to concentrate bacterial contents. The supernatant is decanted and the pellet resuspended. . The resuspended sample is boiled to lyse the bacteria, and the lysed sample cooled and mixed with primers prior to placing the test mixture in a PCR thermocycler.
The thermocycler is run and the PCR results are electrophoresed on an agarose gel, stained with ethydium bromide, and visualized under an ultraviolet light.
Based upon the results of the testing, appropriate measures may be taken to eradicate the spore forming bacteria at the appropriate stage in the process.
EXAMPLE 6 - DETECTING SPORE FORMING BACTERIA IN A BIOLOGICAL
SAMPLE
Samples of 100 mg are taken from fecal matter to be tested. Each 100mg sample to be tested is separately mixed with SO ml tryptic soy broth medium. Following a 7- hour incubation period, samples are centrifuged to concentrate bacterial contents. The supernatant is decanted and the pellet resuspended.
The resuspended sample is boiled to lyse the bacteria, and the lysed sample cooled and mixed with primers prior to placing the test mixture in a PCR thermocycler.
The thermocycler is run and the PCR results are electrophoresed on an agarose gel, stained with ethydium bromide, and visualized under an ultraviolet light.
Based upon the results of the testing, an antibiotic which is effective at treating a spore forming bacterial infection is prescribed.
In each of Examples 4, 5, and 6 (and in other embodiments as well), contaminants may interfere with the ability of the test method to detect spore forming bacteria. For example, the presence of clays, or some enzymes, in a sample may result in an interference with polymerase chain reaction. In such cases, it is recommended that dilution of the original sample be performed until the contaminants are no longer present at an interfering concentration.
Also, with regard to each of Examples 4, 5, and 6, it is noted that while PCR is . taught as a method for detecting hybridization of the probes to the target sample, other methods may be used. For example, a probe may be linked to a fluorescent (other detectable) molecule prior to mixing with the sample. Upon hybridization, and under the proper conditions, the tagged molecule will give off a detectable energy, e.g., fluorescence.
From the foregoing descriptions, one skilled in the art can easily ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to } various usages and conditions.
For example, the inventive nucleotide sequences disclosed herein are selected based on their ability to hybridize target genes of SFB. In particular, the instant nucleotide sequences are directed at conserved target genetic material of SFB. Thus, it is believed that other nucleotide sequences which bind to the target area of SFB genes are within the scope of the present invention.
However, it is recognized that substitution of bases within the inventive nucleotide sequences may still result in hybridization to the target genes. Such substitutions are believed to be within the scope of the present invention, and should amount to an insubstantial difference therefrom.
Additionally, as has been shown, the inventive nucleotide sequences can be combined with other nucleotide sequences and still achieve the same result. This effect is demonstrated in Examples 1 and 2, where modifying only one of the two primers resulted in improved detection. Thus, it is believed that the combinations of the present inventive nucleotide sequences with other nucleotide sequences is within the scope of the present invention.
Claims (40)
1. A probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with : highly conserved regions of the spo0A4 gene of the spore forming bacteria Bacillus and Clostridium bacteria species set out in either (a) or (b) below ’ a) Bacillus cereus Bacillus megaterium Bacillus anthracis, and Clostridium pasteurianum, b) Bacillus cereus Bacillus megaterium Bacillus sphaericus, and Clostridium pasteurianum, said nucleic acid sequence being unable to form a detectable hybrid with genetic material of non-spore forming bacteria.
2. A probe as claimed claim 1 wherein the highly conserved regions of the spo04 gene of spore forming bacteria Bacillus and Clostridium in (a) are and those in (b) are
3. A probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with highly conserved regions of the spo0A4 gene of the spore forming bacteria Bacillus and Clostridium bacteria species set out in either (a) or (b) below a) Bacillus cereus ] Bacillus megaterium Bacillus subtilis, and Clostridium pasteurianums b) Bacillus cereus Bacillus megaterium Bacillus sphaericus, and Clostridium pasteurianum, said nucleic acid sequence being unable to form a detectable hybrid with genetic material of non-spore forming bacteria.
4. A probe as claimed claim 3 wherein the highly conserved regions of the spo04 gene of spore forming bacteria Bacillus and Clostridium in (a) are and those in (b) are
5. A probe as claimed in any one of claims 1 to 4, wherein the nucleic acid sequence comprises at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID
NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
6. A probe as claimed in any one of claims 1 to 5, wherein the nucleic acid sequence . acts as a primer in a polymerase chain reaction used to amplify the detectable hybrid.
7. A probe as claimed in any one of claims 1 to 5, wherein the nucleic acid sequence is tagged with a fluorescent derivative for detection of the detectable hybrid.
8. A probe as claimed in any one of claims 1 to 5, wherein the nucleic acid is tagged with a radioisotope for detection of the detectable hybrid.
09. A probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with the spo0A gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleic acid sequence is able to form a detectable hybrid to bases 76 to 93 of the spo04 gene of Bacillus cereus, corresponding to GenBank accession number gb U09972.
10. The probe of claim 9, wherein the nucleic acid sequence comprises at least one of SEQ ID NO. 4 and SEQ ID NO. 5.
11. A probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with the spo0A gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleic acid ] sequence is able to form a detectable hybrid to bases 403 to 422 of the spo04 gene of Bacillus cereus, corresponding to GenBank accession number gb . U09972.
12. The probe of claim 11, wherein the nucleic acid sequence comprises at least one of SEQ ID NO. 3, SEQ ID NO.6 and SEQ ID NO. 7.
13. A probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with the spo0A gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 70 to 427 of the spo04 gene of Bacillus cereus, corresponding to GenBank accession number gb U09972.
14. A probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with the spo0A gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 570 to 930 of the spoOA4 gene Bacillus subtilis, corresponding to gb M 10082.
15. A probe as claimed in any one of claims 1, 3, 9, 11, 13 or 14 wherein amplification of a portion of the spoOA gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product.
16. A primer set comprising at least one member selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID
NO. 8.
17. A primer set of claim 16 wherein a second member is selected from a group consisting of SEQ ID NO. 5, SEQ ID NO. 6 and SEQ ID NO. 7.
. 18. A nucleic acid sequence comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, and SEQ ID NO. 8.
19. A primer selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4 and SEQ ID NO. 8.
20. A composition comprising at least one cellulose-containing material and at least one primer comprising a sequence selected from the group consisting of SEQ ID . NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7and SEQ ID-NO. 8.
21. The composition of claim 20, wherein the at least one cellulose-containing material comprises paper pulp.
22. Akit for testing for the presence of spore forming bacteria in a paper-making process comprising a) a primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6 and SEQ ID NO. 7, and SEQ ID
NO. 8, and b) at least one medium supportive of spore forming bacterial growth.
23. A method of making a nucleotide sequence for detecting the presence of a conserved gene in spore forming bacteria, characterized in a) determining highly conserved regions of the spoOA gene from at least three Bacillus and one Clostridium species of spore forming bacteria; and b) preparing at least on forward and at least one reverse nucleotide primer sequences able to hybridize to such spoOA4 gene conserved regions of spore forming bacteria, but not to those of non-spore forming bacteria, wherein amplification of a portion of the spo0O4 ) gene from the cellular DNA of such spore forming bacteria by a polymerase chain reaction using such primer sequences results in . the generation of a 346-365 nucleotide long DNA product.
24. The method of claim 23 wherein the highly conserved spoOA gene regions of three Bacillus and one Clostridium species for the preparation of forward primers are and for the preparation of reverse primers are
25. A system for identifying spore forming bacteria comprising: a) means for rendering DNA of the spore forming bacteria susceptible to hybridization with at least one nucleotide probe; b) at least one nucleotide probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with highly conserved regions of the spo0A gene of spore forming bacteria Bacillus and Clostridium bacteria species set out in either i) or ii) below i) Bacillus cereus Bacillus megaterium Bacillus subtilis, and Clostridium pasteurianum; ii) Bacillus cereus } Bacillus megaterium Bacillus sphaericus, and . Clostridium pasteurianum, said nucleic acid sequence being unable to form a detectable hybrid with genetic material of non-spore forming bacteria; and c) means for detecting the hybridization of the DNA of the spore forming bacteria to the at least one nucleotide probe.
26. The system of claim 25 wherein the highly conserved spoOA gene regions of three Bacillus and one Clostridium species for the preparation of forward primers are and for the preparation of reverse primers are
27. A method as claimed in claim 25 wherein the probe is such that amplification of a portion of the spoOA gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product.
28. The system of claim 25, wherein the at least one nucleotide probe comprises a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
29. The system of claim 25, wherein the means for detecting the hybridization does not include the use of a polymerase chain reaction.
30. A method for testing a sample for the presence of spore forming bacteria comprising: a) combining at least two nucleotide primers with a sample,
wherein such nucleotide primers are il) complimentary to at least one forward and at least one reverse nucleic acid sequence from the total cellular DNA of the bacteria, S ii) able to hybridize to such spoOA gene conserved regions of ) spore forming bacteria, but not to those of non-spore forming bacteria, and iii) such that amplification of a portion of the spoO4 gene from the cellular DNA of such spore forming bacteria by a polymerase chain reaction using such nucleotide primer results in the generation of a 346-365 nucleotide long DNA product; and b) amplifying cellular DNA of bacteria in the sample with primers; and c) detecting presence of amplified DNA.
31. The method as claimed in claim 29 wherein the at least two nucleic acid primers comprise at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID
NO. 4, and SEQ ID NO. 8;
32. A method of claim 29 wherein an additional primer is selected from a group consisting of SEQ ID NO. 5, SEQ ID NO. 6 and SEQ ID NO. 7
33. The method of claim 29, wherein the sample comprises at least one of air, soil, or water.
34. The method of claim 29, wherein the sample comprises at least one of blood and fecal matter.
35. The method of claim 29, wherein the sample comprises at least one of starch, protein, and an epichlorohydrin reaction product.
36. A method for the systematic identification of sporulation genes in spore forming bacteria comprising a) combining a tagged or labeled probe as claimed in claim 1 or 2 witha sample, b) hybridizing the probe to the target spore forming bacteria spoOA gene; and c) detecting the hybridized product.
37. A method for the systematic identification of sporulation genes in spore forming bacteria comprising a) combining a tagged or labeled probe as claimed in any one of claims 9, 11, 13 and 14 with a sample, b) hybridizing the probe to the target spore forming bacteria spoOA4 gene; and c) detecting the hybridized product.
38. A method as claimed in claim 36 or 37 wherein the probe is selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
39. A probe as claimed in any one of claims 36 to 38, wherein the nucleic acid sequence is tagged with a fluorescent derivative for detection of the detectable hybrid.
40. A probe as claimed in any one of claims 36 to 38, wherein the nucleic acid is labeled with a radioisotope for detection of the detectable hybrid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200309723A ZA200309723B (en) | 2003-12-15 | 2003-12-15 | Detection of spore forming bacteria. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA200309723A ZA200309723B (en) | 2003-12-15 | 2003-12-15 | Detection of spore forming bacteria. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200309723B true ZA200309723B (en) | 2005-05-25 |
Family
ID=34701592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200309723A ZA200309723B (en) | 2003-12-15 | 2003-12-15 | Detection of spore forming bacteria. |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA200309723B (en) |
-
2003
- 2003-12-15 ZA ZA200309723A patent/ZA200309723B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5928875A (en) | Primers for the detection of spore forming bacteria | |
US8524451B2 (en) | Method for real-time detection of Salmonella in food using a cleavable chimeric probe | |
CN102666872A (en) | Detection of nucleic acids in crude matrices | |
Weingart et al. | Comparison of ethylene production by Pseudomonas syringae and Ralstonia solanacearum | |
AU2003303307A1 (en) | Assay and compositions for detection of bacillus anthracis nucleic acid | |
JP4621919B2 (en) | Multiplex detection method for microorganisms | |
KR20160036528A (en) | Strand-invasion based dna amplification method | |
US20040014122A1 (en) | Detection of spore forming bacteria | |
Seale et al. | Thermophilic Spore‐Forming Bacilli in the Dairy Industry | |
Yoshitomi et al. | Optimization of a 3′-minor groove binder-DNA probe targeting the uidA gene for rapid identification of Escherichia coli O157: H7 using real-time PCR | |
EP1390527A1 (en) | Detection of spore forming bacteria | |
Azokpota et al. | Biodiversity of predominant Bacillus isolated from afitin, iru and sonru at different fermentation time | |
ZA200309723B (en) | Detection of spore forming bacteria. | |
AU2001264621A1 (en) | Detection of spore forming bacteria | |
Hashemi et al. | Isolation of Halophilic Bacteria from Maharlu salt Lake-Iran and their evaluation for the production of bioactive compounds | |
JP7474065B2 (en) | Method for simultaneously detecting multiple bacteria causing spoilage and composition for simultaneously detecting multiple bacteria causing spoilage | |
CA2504911C (en) | Detection, identification and differentiation of eubacterial taxa using a hybridization assay | |
US8133676B2 (en) | Genetic process for multiplex terminal restriction fragment length polymorphism analysis | |
KR20020089391A (en) | Nucleic acid primers of acid-fast bacterium and method of identifying acid-fast bacterium | |
EP0976837A2 (en) | Oligonucleotides for detecting enteric hemorrhagic e. coli and detection method using the same | |
EP3169802B1 (en) | Sequences and their use for detection of listeria monocytogenes | |
MXPA00011565A (en) | Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams | |
CN110475863B (en) | Primer group, probe, kit and method for detecting mycobacterium kansasii | |
US7384770B1 (en) | Rapid quantification of acetic acid-producing bacteria using real-time PCR | |
Škof et al. | REAL‐TIME POLYMERASE CHAIN REACTION FOR DETECTION OF STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA IN PHARMACEUTICAL PRODUCTS FOR TOPICAL USE |